Feasibility of cardiac rehabilitation in patients who have undergone stent insertio

Phase 1

• Conditions: Health Condition 1: null- patients with myocardial infarction who have undergone percutaneous coronary interventionHealth Condition 2: I229- Subsequent ST elevation (STEMI) myocardial infarction of unspecified site

• Registration Number: CTRI/2018/07/014713
• Lead Sponsor: Kasturba Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

patients who have undergone percutaneous coronary intervention (PCI)

Exclusion Criteria

NYHA class IV

Haemodynamically unstable

Unstable angina

Uncompensated heart failure

Significant aortic stenosis

Orthostatic hypotension

Active pericarditis and myocarditis

Uncontrolled arrythmias

Acute pulmonary embolism

Ejection fraction less than 20%

Hypertrophic cardiomyopathy

Recent stroke or transient ischemic attack (TIA)

Palpitation, lethargy and dizziness

Severe psychological disturbances

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility metrics: <br/ ><br>1. Process metrics-Refusal rates, referral rates and recruitment rates <br/ ><br>2. Resource metrics-time of treatment, adherence rate, dropout rate, length of hospital stay <br/ ><br>3. Management metrics-Adverse effects and clinical emergencies <br/ ><br>4. Scientific metrics-response of the study (clinical measures, six-minute walk test, TAMPA heart of kinesophobia, cardiac depression scale, cardiac self-efficacy scale, WHOQOL-BREF)Timepoint: Feasibility metrics: <br/ ><br>1. Process metrics- at the beginning and end of the study <br/ ><br>2. Resource metrics-at the start and end of the study <br/ ><br>3. Management metrics- at the end of the study <br/ ><br>4. Scientific metrics-at the start of the study, on the day of discharge and at the end of the study

Secondary Outcome Measures

Name	Time	Method
six minute walk test, cardiac depression scale, cardiac self-efficacy scale, TAMPA scale of Kinesophobia Heart, WHOQOL-BREF questionnairresTimepoint: on the day of discharge and the end of the study (after 30 days)